ArticlePloS one2020
Detection of amitraz resistance and reduced treatment efficacy in the Varroa Mite, Varroa destructor, within commercial beekeeping operations.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
80 citing papers in PubMed, 186 citations in OpenAlex.
- RNAi targeting ABCB1-like efflux transporters improves miticide efficacy in resistant Varroa mites.Parasites & vectors · 2026Article
- Biological costs and benefits of selective breeding for disease resistance using marker-assisted or field-based selective breeding in honey bees (Apis mellifera).Journal of economic entomology · 2026Article
- Review
- Honey bee hygienic selection impacts virus dynamics of both bees and Varroa mites.Virus research · 2026Article
- Drugs and products in beekeeping: Efficacy and perspectives of natural alternatives.Veterinarni medicina · 2026Review
- Widespread pyrethroid resistance in Varroa destructor in Türkiye: a molecular warning.Experimental & applied acarology · 2026Article
- Honey bee genetic resistance outperforms a cold-storage induced halt in brood production to control mites and viruses.Scientific reports · 2026Article
- Evaluation of late-season Varroa destructor treatments and their impact on amitraz resistant mite populations.Scientific reports · 2026Article
- An RNA interference biopesticide reduces reproduction of the honey bee parasite Varroa destructor by down-regulating embryo development pathways.Pest management science · 2026Article
- Norroa™ as a dsRNA biopesticide forFrontiers in insect science · 2026Review
- Evaluating the new product Norroa™ againstFrontiers in insect science · 2026Article
- BalancingInternational journal for parasitology. Parasites and wildlife · 2025Article
- Field trials of the novel varroacide, 1-allyloxy-4-propoxybenzene, against Varroa destructor in Western Canada.Scientific reports · 2025Article
- Oxalic acid vaporization: effectiveness against Varroa destructor (Mesostigmata: Varroidae) and safety for Apis mellifera (Hymenoptera: Apidae).Journal of insect science (Online) · 2025Article
- Behavioral and molecular disruptions in honey bees induced by lithium chloride exposure.Scientific reports · 2025Article
- Comparative Evaluation of Organic and Commercial Treatments AgainstPathogens (Basel, Switzerland) · 2025Article
- Induced brood breaks by refrigerated bee storage in spring: an effective strategy for Varroa destructor (Mesostigmata: Varroidae) control in honey bee colonies.Journal of insect science (Online) · 2025Article
- Evaluation of Combined Use of Protein and Postbiotics Feed Supplements in Honey Beehives in Autumn and Spring.Probiotics and antimicrobial proteins · 2025Article
- Treating newly split Apis mellifera honey bee colonies with organic miticides-an opportunity for Integrated Pest Management of Varroa destructor mites (Mesostigmata: Varroidae).Journal of economic entomology · 2025Article
- Subtle effects of acetone and amitraz on sucrose sensitivity and recall in honey bees.Scientific reports · 2025Article
20 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The parasitic mite Varroa destructor and the associated viruses it transmits are responsible for most instances of honey bee colony losses in the United States. As such, beekeepers utilize miticides to control Varroa populations. Widespread resistance has developed to the miticides fluvalinate and coumaphos. However, Varroa has largely maintained susceptibility to amitraz despite a long and extensive use history. Anecdotal reports of reduced amitraz effectiveness have been a widely discussed contemporary issue among commercial beekeepers. Amitraz resistance was measured by in vitro bioassays with technical amitraz as well as Apivar® efficacy tests. Amitraz resistance was evaluated in commercial beekeeping operations in Louisiana, New York, and South Dakota with a long history of amitraz use. This research shows that amitraz remains an effective Varroa control product in many operations. However, apiaries across operations displayed a wide range of amitraz resistance from no resistance to high resistance that resulted in Varroa control failure. The resistance ratios from in vitro amitraz bioassays were correlated with reduced Apivar® efficacy, demonstrating bona fide cases of Varroa control failures due to amitraz resistance. Therefore, amitraz resistance monitoring protocols need to be developed. A resistance monitoring network should be established to ensure the sustainability of miticide use for Varroa control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.